Unlock instant, AI-driven research and patent intelligence for your innovation.

Coding polynucleotide of human protein with function of suppressing cancer cell growth

A polynucleotide and encoding technology, applied in the use and preparation of polynucleotides and polypeptides, in the field of polypeptides encoded by polynucleotides, can solve problems such as lack of functional gene high-throughput

Inactive Publication Date: 2004-11-24
NEWORGEN
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Human genomics research is currently a hot spot in the world. In addition to large-scale sequencing of human chromosome DNA and expressed sequence sequencing (EST), there is still a lack of high-throughput methods for screening functional genes starting from function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] Example 1: Obtaining of cDNA gene and its inhibitory effect on cancer cell clone formation

[0085] PP2030, PP2243, PP6569, PP7080, PP7302, PP7759, PP8304, PP8675, PP9455, PP9748, PP9932 and PP10141 were obtained by constructing a human placenta cDNA library by conventional methods. Placental tissues at 3, 6, and 9 months old were taken, and total RNA was extracted with Trizol reagent (GIBCO BRL Company) according to the manufacturer's instructions, and mRNA was extracted with an mRNA purification kit (Pharmacia Company). The cDNA library of the above mRNA was constructed with the pCMV-script TMXR cDNA library construction kit (Stratagene). The reverse transcriptase was changed to MMLV-RT-Superscript II (GIBCO BRL), and the reverse transcription reaction was carried out at 42°C. Transformed XL 10-Gold competent cells, obtained 1 × 10 6 cDNA library for cfu / μg cDNA titer. In the first round, cDNA clones were randomly selected, and then high-abundance cDNA clones and c...

Embodiment 2

[0088] Example 2: Obtain full-length gene and recombinant protein expression by PCR from placenta cDNA

[0089] Human placental tissues aged 3, 6, and 9 months were taken, and total RNA was extracted with Trizol reagent (GIBCO BRL Company) according to the manufacturer's instructions, and mRNA was extracted with an mRNA purification kit (Pharmacia Company). Use MMLV-RT-SuperscriptII (GIBCO BRL) and reverse transcriptase to perform reverse transcription at 42°C to obtain placental cDNA. Use specific primers for each gene (as shown in the table below), and perform 3'1 cycles at 97°C. 94°C 30″, 60°C 30″, 72°C 1′ 35 cycles, 72°C 10′ 1 cycle for PCR amplification to obtain the amplified products of each protein gene containing the complete open reading frame sequence. The amplified product was verified by sequencing and was consistent with the sequence measured in Example 1, and then the amplified product was transferred to a host cell using conventional techniques to obtain a rec...

Embodiment 3

[0091] Embodiment 3: cDNA clone sequence analysis

[0092] 1. PP2030

[0093] A: Nucleotide sequence (SEQ ID NO: 1) Length: 2144 bases

[0094] 1 GCAACATGGC GGCTGCCGTG GTGCAGCGCC CGGGCTGAGC GACAGCAAGT GCAGCGGGCT

[0095] 61 CCTACCCCGG GTGAGGGGTG GCCTCCGCGT TGGATCGTGC CCTCTTCAGC CCGCTCCTGT

[0096] 121 CCCCGACATC ACGTGTATTC CGCACGTCCC CTCCGCGCTG TGTGTCTACT GAGACGGGGA

[0097] 181 GGCGTGACAG GGCCCGGGTC CCTTCTCAGT GGTGCTCTGT GCTTCAGGGC AAGCTCCCCG

[0098] 241 TCTCCGGGCG CACTTCCCTC GCCTGTGTTC GGTCCATCCT CCTTTCTCCA GCCTCCTCCC

[0099] 301 CTCGCAGGCG GATGACCCGG ACGACGGGCC AGTGCCTGGC ACCCCGGGGTGCCAGGGTC

[0100] 361 CACGGGGAAC CCGAAGTCCG AGGAGCCCGA GGTCCCGGAC CAGGAGGGGC TGCAGCGCAT

[0101] 421 CACCGGCCTG TCTCCCGGCC GTTCGGCTCT CATAGTGGCG GTGCTGTGCT ACATCAATCT

[0102] 481 CCTGAACTAC ATGGACCGCT TCACCGTGGC TGGCGTCCTT CCCGACATCG AGCAAGTTCT

[0103] 541 TCAACATCGG GGACAGTAGC TCTGGGCTCA TCCAGACCGT GTTCATCTCC AGTTACATGG

[0104] 601 TGTTGGCACC TGTGTTTGGC TACCTGGGTG AC...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses one kind of human protein with cancer suppressing function, polynucleotides encoding the polypeptide and the recombinant process of producing the polypeptide. The present invention also discloses the method of using the polypeptide in treating various diseases, such as cancer. The present invention also discloses the agonist resisting the polypeptide and its treatment effect. The present invention also discloses the application of the polynucleotides encoding the human protein with cancer suppressing function.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular, the invention relates to a new polynucleotide encoding a human protein with tumor suppressor function and a polypeptide encoded by the polynucleotide. The present invention also relates to the use and preparation of such polynucleotides and polypeptides. Background technique [0002] Human genomics research is currently a hot spot in the world. In addition to large-scale sequencing of human chromosomal DNA and expressed sequence sequencing (EST), there is still a lack of high-throughput methods for screening functional genes starting from function. [0003] Cancer is one of the major diseases that endanger human health. In order to effectively treat and prevent tumors, people have paid more and more attention to gene therapy of tumors. Therefore, there is an urgent need in this field to develop and study human proteins with tumor suppressor functions and their agonists / inhibitors. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H21/00C07K14/435C07K16/18C12N15/10C12N15/12C12N15/63C12N15/64C12P21/02
Inventor 顾健人杨胜利
Owner NEWORGEN